. . . "Doposud nebyly pops\u00E1ny \u017E\u00E1dn\u00E9 l\u00E9kov\u00E9 interakce.\nL\u00E9\u010Div\u00E9 p\u0159\u00EDpravky, kter\u00E9 ovliv\u0148uj\u00ED myokardi\u00E1ln\u00ED funkci nebo krevn\u00ED pr\u016Ftok, mohou zp\u016Fsobit fale\u0161n\u011B negativn\u00ED v\u00FDsledky p\u0159i\u00A0diagnostice ischemick\u00E9 choroby srde\u010Dn\u00ED. Z\u00A0tohoto d\u016Fvodu je nutno p\u0159i interpretaci v\u00FDsledk\u016F scintigrafick\u00E9ho vy\u0161et\u0159en\u00ED br\u00E1t v\u00A0\u00FAvahu st\u00E1vaj\u00EDc\u00ED medikaci.\n"@cs . . "004.005" . "4.5 \tInterakce s jin\u00FDmi l\u00E9\u010Div\u00FDmi p\u0159\u00EDpravky a jin\u00E9 formy interakce"@cs .